REN-1189

• CAT Number: I009006
• CAS Number: 183619-38-7
• Molecular Formula: C13H18N2O2
• Molecular Weight: 234.30
• Purity: ≥95%
• Synonyms: CPI-1189; REN-1189; REN-1654; CPI1189; REN1189; REN1654; CPI 1189; REN 1189; REN 1654;4-acetamido-N-(tert-butyl)benzamide
• Target: TNF Receptor
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: 4-acetamido-N-tert-butylbenzamide
• InChI: InChI=1S/C13H18N2O2/c1-9(16)14-11-7-5-10(6-8-11)12(17)15-13(2,3)4/h5-8H,1-4H3,(H,14,16)(H,15,17)
• InChIKey: DJKNRCWSXSZACF-UHFFFAOYSA-N
• SMILES: CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C

REN-1189 (Cat.No:I009006) is an experimental small molecule compound under investigation for its potential in cancer therapy. It acts as a selective inhibitor of the protein kinase CK2, which plays a key role in regulating cellular growth, survival, and proliferation. By inhibiting CK2, REN-1189 may disrupt tumor cell growth and induce apoptosis in cancer cells. Preclinical studies suggest it could be effective against a variety of cancers, though further clinical testing is required to assess its safety, efficacy, and therapeutic potential.